PAREXEL RECIST 1.1

Learn about RECIST 1.1 and how it can be applied to your clinical trial.

RECIST (Response Evaluation Criteria In Solid Tumors) is a set of published rules that define when cancer patients improve ("respond"), stay the same ("stable") or worsen ("progression") during treatments.